z-logo
open-access-imgOpen Access
Biogenic synthesis of copper oxide nanoparticles using leaf extracts of Cissus quadrangularis and Piper betle and its antibacterial effects
Author(s) -
Kasi Sofiya Dayana,
Ramasamy Jothi Mani,
Nagaraj Dharmalingam,
Santiyagu Valanarasu,
Ponraj Joice Sophia
Publication year - 2021
Publication title -
micro and nano letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.25
H-Index - 31
ISSN - 1750-0443
DOI - 10.1049/mna2.12066
Subject(s) - piper , nanoparticle , chemistry , nuclear chemistry , transmission electron microscopy , piperaceae , antibacterial activity , copper , materials science , scanning electron microscope , polyphenol , crystallite , nanotechnology , traditional medicine , organic chemistry , antioxidant , medicine , biology , bacteria , crystallography , composite material , genetics
Owing to its environment‐friendly, biocompatible, non‐toxic nature of nanoparticles attained from green plant extract, it has remarkable significance in the field of nanotechnology towards effective biomedical application. This work reports the synthesis of copper oxide nanoparticles by means of Cissus quadrangularis and Piper betle via green‐synthesis route. The medicinal leaf extracts possessing phytochemicals such as alkaloids and polyphenols act as a reducing agent in the current synthesis. The characterization of functional groups of CuO NPs by two different leaf extracts was investigated by FTIR analysis which measures reduction and stabilization of CuO NPs. X‐ray diffraction confirms the orthorhombic structure with an average crystallite size of about 32.54 and 32.09 nm. The irregular spherical‐shaped morphology of the samples is evidenced from scanning electron microscopy analysis. The transmission electron microscopy images demonstrated 50 nm sized prepared CuO nanoparticles. The bioactivity of the prepared sample is confirmed from antibacterial studies and zeta potential.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here